Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

EIDX

Eidos Therapeutics (EIDX)

Eidos Therapeutics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:EIDX
DataHoraFonteTítuloCódigoCompanhia
05/02/202118:32Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:EIDXEidos Therapeutics Inc
28/01/202108:05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:EIDXEidos Therapeutics Inc
26/01/202118:05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:EIDXEidos Therapeutics Inc
26/01/202111:01Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:EIDXEidos Therapeutics Inc
26/01/202110:48Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:EIDXEidos Therapeutics Inc
26/01/202110:47Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EIDXEidos Therapeutics Inc
26/01/202110:30GlobeNewswire Inc.BridgeBio Pharma, Inc. Announces Completion of Merger with Eidos Therapeutics, Inc.NASDAQ:EIDXEidos Therapeutics Inc
19/01/202118:01GlobeNewswire Inc.Stockholders of BridgeBio Pharma, Inc. and Eidos Therapeutics, Inc. Approve BridgeBio Pharma, Inc. Acquisition of Eidos Thera...NASDAQ:EIDXEidos Therapeutics Inc
13/01/202118:50Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:EIDXEidos Therapeutics Inc
13/01/202118:30GlobeNewswire Inc.BridgeBio Pharma, Inc. and Eidos Therapeutics, Inc. Announce January 21, 2021 Election Deadline for MergerNASDAQ:EIDXEidos Therapeutics Inc
04/01/202109:30GlobeNewswire Inc.Leading Independent Proxy Advisory Firm ISS Recommends BridgeBio Pharma and Eidos Therapeutics Stockholders Vote “FOR” Pr...NASDAQ:EIDXEidos Therapeutics Inc
15/12/202011:31Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (defm14a)NASDAQ:EIDXEidos Therapeutics Inc
05/11/202009:30GlobeNewswire Inc.BridgeBio Pharma, Inc. Reports Third Quarter 2020 Financial Results And Business UpdateNASDAQ:EIDXEidos Therapeutics Inc
29/10/202017:48Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:EIDXEidos Therapeutics Inc
29/10/202017:30GlobeNewswire Inc.Eidos Therapeutics Reports Third Quarter 2020 Financial Results and Business UpdateNASDAQ:EIDXEidos Therapeutics Inc
05/10/202008:04GlobeNewswire Inc.BridgeBio Pharma and Eidos Therapeutics Announce Merger AgreementNASDAQ:EIDXEidos Therapeutics Inc
10/08/202020:24Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:EIDXEidos Therapeutics Inc
07/08/202017:30GlobeNewswire Inc.Eidos Therapeutics Appoints Industry Leaders With Significant Development and Commercial Expertise to Board of DirectorsNASDAQ:EIDXEidos Therapeutics Inc
06/08/202017:30GlobeNewswire Inc.Eidos Therapeutics Reports Second Quarter 2020 Financial Results and Business UpdateNASDAQ:EIDXEidos Therapeutics Inc
09/06/202017:01Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:EIDXEidos Therapeutics Inc
08/05/202017:30GlobeNewswire Inc.Eidos Therapeutics Reports First Quarter 2020 Financial Results and Business UpdateNASDAQ:EIDXEidos Therapeutics Inc
24/04/202017:09Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:EIDXEidos Therapeutics Inc
24/04/202017:06Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:EIDXEidos Therapeutics Inc
08/04/202011:31Edgar (US Regulatory)Other FilingNASDAQ:EIDXEidos Therapeutics Inc
26/02/202018:43Edgar (US Regulatory)Annual Report (10-k)NASDAQ:EIDXEidos Therapeutics Inc
26/02/202018:30GlobeNewswire Inc.Eidos Therapeutics Reports Fourth Quarter and Year-End 2019 Financial Results and Business UpdateNASDAQ:EIDXEidos Therapeutics Inc
11/02/202014:58Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:EIDXEidos Therapeutics Inc
16/11/201920:58GlobeNewswire Inc.CORRECTION: BridgeBio and Eidos Present Data from Phase 2 Open Label Extension Suggesting Long-term Tolerability of AG10 and ...NASDAQ:EIDXEidos Therapeutics Inc
16/11/201919:30GlobeNewswire Inc.BridgeBio and Eidos Present Data from Phase 2 Open Label Extension Suggesting Long-term Tolerability of AG10 and Stabilizatio...NASDAQ:EIDXEidos Therapeutics Inc
31/10/201917:30GlobeNewswire Inc.Eidos Therapeutics Reports Third Quarter 2019 Financial Results and Business UpdateNASDAQ:EIDXEidos Therapeutics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:EIDX